BRIEF-Retrophin says it was advised that Thiola removed from FDA drug shortage list

* Advised by Mission Pharmacal Company that Thiola has been removed from FDA drug shortage list - sec filing Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.